Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. [electronic resource]
Producer: 20160908Description: 587-601 p. digitalISSN:- 1878-3686
- Adenocarcinoma -- drug therapy
- Apoptosis -- drug effects
- Chemokine CCL5 -- antagonists & inhibitors
- Chemokines -- physiology
- Chemotaxis
- Clinical Trials, Phase I as Topic
- Clodronic Acid -- pharmacology
- Colorectal Neoplasms -- immunology
- Cyclohexanes -- pharmacology
- Humans
- Interferon-alpha -- metabolism
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymphocytes, Tumor-Infiltrating -- immunology
- Macrophages -- drug effects
- Maraviroc
- Molecular Targeted Therapy
- NG-Nitroarginine Methyl Ester -- pharmacology
- Neoplasm Invasiveness
- Neoplasm Proteins -- antagonists & inhibitors
- Phenylurea Compounds -- therapeutic use
- Pilot Projects
- Pyridines -- therapeutic use
- Receptors, CCR5 -- drug effects
- STAT3 Transcription Factor -- physiology
- Survival Analysis
- Triazoles -- pharmacology
- Tumor Cells, Cultured
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.